U.S. transthyretin amyloidosis treatment market statistics, by therapy, 2018-2030 (USD Million)
US transthyretin amyloidosis treatment market outlook size was valued at 2,214.0 USD million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2030.